Diagnosis of Head and Neck Cancer (HNC) presents a multifarious problem. Late stage diagnosis, functional loss resulting in reduced Quality of Life, fear, stress, malnutrition and uncertainty throughout the cancer treatment experiences. Searching of biomarkers specific for high risk tumors in early stages is really essential. In the present study, we identified the prevalence of HNC was 45.2% underscoring an urgent need to better understand the biological bases of this type of cancer in this region. We chose to address this challenge by studying the role of antioxidative, immune markers, and XRCC1 DNA repair gene in HNC patients. Dietary protein supplementation to Head and Neck Cancer cases undergoing treatment had a beneficial effect by improving their nutrient intakes, anthropometric status, antioxidative and immune markers of the HNC patients. Cancer cases by offering good protection to normal cells, which may further reduce the risk of developing secondary cancers. CD44 appears to be a fair marker of HNC and to have potential diagnostic value, because its detection is easy in terms of final outcomes.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr.Kereena Chukka has done her PhD in Head and Neck Cancer biology from the Department of Biotechnology, Acharya Nagarjuna University, Guntur, India. She has been published 25 research papers in reputed scientific journals. Her research interests are Cancer Biology, Medical Genetics, Molecular Biology, In-Vivo & In-Vitro, Immunology.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Diagnosis of Head and Neck Cancer (HNC) presents a multifarious problem. Late stage diagnosis, functional loss resulting in reduced Quality of Life, fear, stress, malnutrition and uncertainty throughout the cancer treatment experiences. Searching of biomarkers specific for high risk tumors in early stages is really essential. In the present study, we identified the prevalence of HNC was 45.2% underscoring an urgent need to better understand the biological bases of this type of cancer in this region. We chose to address this challenge by studying the role of antioxidative, immune markers, and XRCC1 DNA repair gene in HNC patients. Dietary protein supplementation to Head and Neck Cancer cases undergoing treatment had a beneficial effect by improving their nutrient intakes, anthropometric status, antioxidative and immune markers of the HNC patients. Cancer cases by offering good protection to normal cells, which may further reduce the risk of developing secondary cancers. CD44 appears to be a fair marker of HNC and to have potential diagnostic value, because its detection is easy in terms of final outcomes. 172 pp. Englisch. Bestandsnummer des Verkäufers 9786202315470
Anzahl: 2 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Chukka KereenaDr.Kereena Chukka has done her PhD in Head and Neck Cancer biology from the Department of Biotechnology, Acharya Nagarjuna University, Guntur, India. She has been published 25 research papers in reputed scientific journ. Bestandsnummer des Verkäufers 385941649
Anzahl: Mehr als 20 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. Bestandsnummer des Verkäufers 26395126839
Anzahl: 4 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Print on Demand. Bestandsnummer des Verkäufers 402298856
Anzahl: 4 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND. Bestandsnummer des Verkäufers 18395126845
Anzahl: 4 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Immunity and Genetic Polymorphisms of Head and Neck Cancer | Kereena Chukka | Taschenbuch | 172 S. | Englisch | 2018 | Scholars' Press | EAN 9786202315470 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. Bestandsnummer des Verkäufers 114448709
Anzahl: 5 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Diagnosis of Head and Neck Cancer (HNC) presents a multifarious problem. Late stage diagnosis, functional loss resulting in reduced Quality of Life, fear, stress, malnutrition and uncertainty throughout the cancer treatment experiences. Searching of biomarkers specific for high risk tumors in early stages is really essential. In the present study, we identified the prevalence of HNC was 45.2% underscoring an urgent need to better understand the biological bases of this type of cancer in this region. We chose to address this challenge by studying the role of antioxidative, immune markers, and XRCC1 DNA repair gene in HNC patients. Dietary protein supplementation to Head and Neck Cancer cases undergoing treatment had a beneficial effect by improving their nutrient intakes, anthropometric status, antioxidative and immune markers of the HNC patients. Cancer cases by offering good protection to normal cells, which may further reduce the risk of developing secondary cancers. CD44 appears to be a fair marker of HNC and to have potential diagnostic value, because its detection is easy in terms of final outcomes.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 172 pp. Englisch. Bestandsnummer des Verkäufers 9786202315470
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Diagnosis of Head and Neck Cancer (HNC) presents a multifarious problem. Late stage diagnosis, functional loss resulting in reduced Quality of Life, fear, stress, malnutrition and uncertainty throughout the cancer treatment experiences. Searching of biomarkers specific for high risk tumors in early stages is really essential. In the present study, we identified the prevalence of HNC was 45.2% underscoring an urgent need to better understand the biological bases of this type of cancer in this region. We chose to address this challenge by studying the role of antioxidative, immune markers, and XRCC1 DNA repair gene in HNC patients. Dietary protein supplementation to Head and Neck Cancer cases undergoing treatment had a beneficial effect by improving their nutrient intakes, anthropometric status, antioxidative and immune markers of the HNC patients. Cancer cases by offering good protection to normal cells, which may further reduce the risk of developing secondary cancers. CD44 appears to be a fair marker of HNC and to have potential diagnostic value, because its detection is easy in terms of final outcomes. Bestandsnummer des Verkäufers 9786202315470
Anzahl: 1 verfügbar